Ginwa Enterprise (Group) Inc. (SHA:600080)

China flag China · Delayed Price · Currency is CNY
7.10
-0.01 (-0.14%)
Jun 16, 2025, 2:45 PM CST
11.64%
Market Cap 2.50B
Revenue (ttm) 577.00M
Net Income (ttm) 51.86M
Shares Out 352.71M
EPS (ttm) 0.15
PE Ratio 48.50
Forward PE n/a
Dividend 0.03 (0.42%)
Ex-Dividend Date n/a
Volume 3,010,000
Average Volume 4,671,311
Open 7.10
Previous Close 7.10
Day's Range 7.06 - 7.18
52-Week Range 5.58 - 8.65
Beta 0.28
RSI 42.48
Earnings Date Aug 18, 2025

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells pharmaceuticals in China. The company offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. It offers its products in the form of tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. In addition, the company provides chemical drugs, Chinese medicines, raw materials, and health related products. Ginwa Enterprise (Group) Inc. was found... [Read more]

Sector Healthcare
Founded 1996
Employees 588
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.